Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Aluminum in Vaccines: Mechanisms, Myths, and Safety Data

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and scientific findings. It also highlights new developments in vaccine adjuvant technology and the ongoing need for rigorous monitoring.

Vaccine Delivery

The Future of Vaccines

Plant-Derived Vaccines

Vaccination in Humanitarian Settings

How Veterinary Vaccines Affect Human Health

What are Adenovirus-Based Vaccines?

What are the Different Types of Vaccines?

What is an RNA Vaccine?

Hib Immunization

What the Newest mRNA Vaccines Could Do Beyond COVID

How are Vaccines Stored?

See more featured articles »

What is a Subunit Vaccine?

Vaccine Excipients

Transforming Vaccine Design: The Promise of Systems Biology

History of Vaccination

What is a Toxoid Vaccine?

What are Vaccines?

Immunization strategies: What lessons can we learn from successful campaigns?

Vaccine History

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

What is a Live-Attenuated Vaccine?

Could there be a Salmonella Vaccine?

Insight into Personalized Vaccines

What is the Importance of Vaccination Coverage?

What is Immunobridging?

Investigating the Importance of Investing in Vaccine Manufacturing

What is a Vaccine Breakthrough?

What are the Main Causes of Vaccine Hesitancy?

Vaccine Schedule

What are Nanoparticle-Based Vaccines?

What is a DNA Vaccine?

Vaccine Effectiveness

What is a VLP Vaccine?

Vaccine Immunity

Vaccine Production

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

What is an Inactivated Vaccine?

The Essential Program on Immunization is 50: Milestones, achievements, and future directions

Role of Computer Modeling in Vaccine Development

What is a Non-Replicating Vaccine?

Latest Vaccine News and Research

Hybrid polymer nanocarriers enable efficient inhaled mRNA vaccine delivery to the lungs

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

16 Jan 2026

Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and immune checkpoint inhibitor drugs, but it's not always clear which therapy is inducing what type of response.

16 Jan 2026

Investigational cancer vaccine shows early promise for cancer prevention in Lynch syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.

16 Jan 2026

PRoRota-project aims to fight diarrhea in children using probiotics, hygiene, and models

The PRoRota-project will use probiotics, improved education in hygiene and advanced mathematical models to prevent children from dying of diarrhea in low and middle-income countries.

16 Jan 2026

Cervical cancer association with unsafe sex and smoking

The study reveals deep inequalities in cervical cancer mortality linked to smoking and unsafe sex, highlighting the need for targeted prevention strategies.

15 Jan 2026

Immune dysfunction persists after combined TB and HIV therapy

The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – following the international gold standard for treating people with latent tuberculosis (TB) and HIV, a team at Texas Biomedical Research Institute reports in Nature Communications.

14 Jan 2026

Age-tailored therapies needed for treating the young and old with sepsis

Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and monitor its immune response to prevent collateral damage.

14 Jan 2026

Vaccines are helping older people more than we knew

Let's be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can cause lingering nerve pain and other nasty long-term consequences.

14 Jan 2026

New European initiative aims to transform real world Alzheimer’s disease care

Today, the ACCESS-AD consortium is announcing the launch of a transformative European initiative that will accelerate the implementation of scientific innovations for Alzheimer's disease (AD) management in real-world health systems.

13 Jan 2026

Long-term study reveals shifting patterns in COVID-19 vaccine hesitancy

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people in England between January 2021 and March 2022 during the COVID-19 pandemic, published in The Lancet.

13 Jan 2026

RFK Jr.’s MAHA movement has picked up steam in statehouses. Here’s what to expect in 2026.

When one of Adam Burkhammer's foster children struggled with hyperactivity, the West Virginia legislator and his wife decided to alter their diet and remove any foods that contained synthetic dyes.

13 Jan 2026

Blood test opens the doors to early diagnosis and prevention of Crohn's disease

Sinai Health researchers have shown a blood test that can predict Crohn's disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention.

12 Jan 2026

School-based HPV vaccination protects even unvaccinated women

High HPV vaccination rates in Swedish schools significantly lower cervical cancer lesion rates, highlighting the importance of universal immunization programs.

12 Jan 2026

Aston Sci. Inc. implements CDD Vault to support AI-driven cancer vaccine development

Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced today that it has implemented CDD Vault®, the secure, cloud-based research informatics platform from Collaborative Drug Discovery (CDD).

From Collaborative Drug Discovery, Inc. 10 Jan 2026

Ultrasound-responsive nanocatchers enable precise in-situ tumor antigen capture

Professor Zhaohui Tang and Associate Professor Zhilin Liu from the team of Professor Xuesi Chen at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, developed ultrasound-responsive in-situ antigen nanocatchers (S-nanocatchers), achieving precise spatiotemporal capture of tumor antigens and controllable acquisition of in-situ vaccines.

9 Jan 2026